KEYNOTE SPEAKERS
Hani Abouhalka, MBA
Company Group Chairman, Medical Devices EMEA, Johnson & Johnson, New Brunswick, NJ, USA
Gemma Aiolfi
Head of Compliance, Corporate Governance and Collective Action, Basel, Switzerland
Pedro Carrascal, MBA
President, European Multiple Sclerosis Platform (EMSP), Chief Executive Officer, EME (Multiple Sclerosis Spain), Biscay MS Society and MS Basque Foundation, Board, Multiple Sclerosis International Federation (MSIF), Bilbao, Spain
Roxana Family, Thèse de Doctorat Droit
Vice-President, Chair in Law & Business Ethics and Program Director, Cergy Pontoise University, Cergy-Pontoise, France
David Fuhr, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC, USA
Clément Grospiron
Mission Head to the Chief Supervision Directorate, Agence Française Anti-corruption (AFA), Paris, France
Kirt Kraeuter, MGA
Senior Director, Corporate Compliance, Moderna; Former European Compliance Director, Otsuka; Former, Executive Director, Worldwide Compliance Committee & Monitoring, Bristol-Myers Squibb; Yardley, PA, USA
Anna-Elisabeth Krause-Ablass, JD
European Delegated Prosecutor, European Public Prosecutor's Office; Former Specialized Public Prosecutor for White Collar Crime Frankfurt, Frankfurt, Germany
Judy Krieg, JD
Head of Fraud, Bribery and Corruption, Division B, UK Serious Fraud Office; Former Chief Compliance Officer, Rolls-Royce plc, London, UK
Sally Molloy, JD
Chief, Strategy, Policy & Training Unit, Fraud Section; Former Assistant U.S. Attorney, US Attorney's Office, Northern District of Georgia, US Department of Justice; Washington, DC, USA
Piergiorgio Pepe, MA
EU Law, President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo; Former Compliance Director Western Europe & Canada, AbbVie; Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb; Paris, France
N. Craig Smith
Chaired Professor of Ethics and Social Responsibility, Academic Director of ESRI (the INSEAD Ethics and Social Responsibility Initiative), and Programme Director for the Healthcare Compliance, Implementation Leadership Programme, INSEAD, Fontainebleau, FranceFEATURING SENIOR ETHICS AND COMPLIANCE PROFESSIONALS ROUNDTABLE
Adam Dubow, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Princeton, NJ, USA
Mwana Lugogo, JD, MPP
Chief Ethics and Compliance Officer, Takeda Pharmaceuticals International GmBh, Zurich, Switzerland
Pascale Schmidt
Chief Compliance Officer and Chair, Corporate Sustainability Committee F. Hoffmann-La Roche Ltd, Basel, Switzerland
Trudy Tan
Global Head Ethics, Risk & Compliance, Pharma, Novartis; Former Vice President Compliance, International, AstraZeneca; Basel, Switzerland
Mariusz Witalis
Partner, Forensic & Integrity Services, EY, Warsaw, PolandFEATURED FACULTY
Matt Abrahamson, MBA
Senior Compliance Analyst, DH Diagnostics LLC, a Danaher company, Buffalo Grove, IL, USA
Michaela Ahlberg, LLM, CCEP, CCEP-I
Senior Advisor, Getinge; Ethics & Compliance and Anti Bribery Corruption Specialist, TheGreyZone, Göteborgsområdet, Sweden
Sobia Akram, MSC
Corporate Vice President, Global Business Ethics Compliance Office & Programme, Novo Nordisk A/S, Copenhagen, Capital Region, Denmark
Imelda Álvarez, LLB, MBA
Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head Latin America and Canada, Novartis; Mexico City, Mexico
Ghadeer Al Yacoub, MSc
Regional Head Healthcare Compliance Europe, Middle East and Africa Medical Devices, Johnson & Johnson, Dubai, UAE
Bas Amesz, MSc
Partner, Vintura, Baarn, Utrecht, Netherlands
Michael Bartke, PhD
Strategic Committee, ETHICS; Former Director Ethics & Compliance, Alexion; Former Director Compliance Management, Daiichi, Sankyo, Europe Munich, Germany
Ann Beasley, JD
Chief Compliance Officer, Zai Lab; Former Senior Vice President, Chief Compliance Officer, Biogen; Former Global Compliance Office, Novartis Pharma AG; Boston, MA, USA
Duygu Beyazo, LLB
Senior Associate, NSN Law Firm; Former Compliance Manager (Secondment), Business Conduct, Gilead Sciences; Istanbul, Turkey
Stefano Biondi, LLB, PhD
Compliance Manager and Group Data Protection Officer, Menarini Group, Florence, Italy
Richard Bistrong, MA
Chief Executive Officer, Front-Line Anti-Bribery LLC; Contributing Editor, FCPA Blog; Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ; New York, NY, USA
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Raleigh-Durham, NC, USA
Julie Bonhomme
Legal & Compliance Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium
Nicola Bonucci, MA, DEA, DESS
Partner, Global Trade and Investigations & White Collar Defense, Paul, Hastings; Former Director of Legal Affairs, Organisation for Economic Cooperation and Development's (OECD), Paris, France
Eric J. Bottelier
Director, Ethics, Risk & Compliance, US Oncology, Novartis Pharmaceuticals Corporation; Former NA Compliance & Business Ethics, Sanofi, Erwinna, Pennsylvania
Amanda Bunten, DPsych
Chartered Health Psychologist; Director of Behavioral Ethics, GlaxoSmithKline;Former Principal Behavioural Insights Advisor,Public Health England, London, UK
Keith Burn
Global Investigations Director, Ipsen; Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS; Former Detective Constable, London Metropolitan Police; Slough, UK
Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme; Former Senior Manager NA Compliance, Sanofi; Jamaica Plain, MA, USA
Kishwar Chishty, ACA
Partner Risk Advisory Life Sciences, Deloitte Switzerland, Basel, Switzerland
Ana Christian, JD
Senior Director, Assistant General Counsel, Avanir Pharmaceuticals; Former Corporate Counsel, NantHealth,Los Angeles, CA, USA
Michael R. Clarke, JD, CCEP
Vice President, Global Chief Compliance Officer, ConvaTec; Former Vice President, Corporate Compliance, Indivior; Former Vice President, Ethics & Compliance, Americas, Actavis; Bridgewater, NJ, USA
Zachary N. Coseglia, JD
Managing Principal and Head of Innovation, R&G Insights Lab, Ropes & Gray, LLP, Boston, MA, USA
Rika De Ville
Vice President Global Compliance & Privacy, Data Protection Officer, Perrigo Company plc Nazareth, Belgium
Stefanie Deronne, JD
Legal Counsel, Argenx; Former Senior Corporate Legal Counsel R&D - DPO, Ablynx; Ghent, Belgium
Anisa Dhalla
Global Chief Compliance Officer, UCB, Inc., Atlanta, GA, USA
Holger Diener
Healthcare Compliance Officer, Janssen-Cilag GmbH, Johnson & Johnson; Former Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry (“FSA”), Berlin, Germany
Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany
Kalwant Dhindsa, CIPP/E, CCEP
Compliance Director, Convatec; Former Senior Corporate Compliance Counsel, Bayer; Reading, UK
Laetitia Ducroquet
Vice-President, Global Business Ethics, Ipsen, Boulogne Billancourt, France
Sue Egan
Director and Principal Consultant, Sue Egan Associates; Former Vice President Compliance, AstraZeneca; Great Missenden, Buckinghamshire, UK
Signe Elbæk, JD, LLM
Visitor Researcher, Faculty of Law, University of Copenhagen; Former Group Chief Compliance Officer, Coloplast; Former Vice Chair, Ethics and Compliance Committee and Member of the Code Committee, MedTech Europe; Former Compliance Manager, Attorney, Dako Denmark A/S; Copenhagen, Denmark
Jacob Elberg, JD
Associate Professor, Seton Hall University School of Law; Former Chief, Health Care & Government Fraud Unit, and Assistant US Attorney US Attorney's Office, District of New Jersey; Newark, NJ, USA
Robert Ennis, JD, LLM
Vice President and Lead Compliance Counsel, Pfizer, New York, NY
Martin Eschbach, JD
Head Ethics, Risk and Compliance and Legal Patient Engagement, Novartis International AG, Baden-Württemberg, Germany
Steffen Esche
Director, Consulting, Risk & Regulatory, PwC, Frankfurt, Germany
J. Mark Farrar, MSJ, CPA
Managing Director, Compliance Group Leader, Epsilon Life Sciences; Atlanta, GA
Alex Fell
Head Ethics, Compliance and DPO International, Amicus Therapeutics; Former Vice President, Global Ethics and Compliance, Head of Strategy, Planning and Operations, GSK; London, UK
George Fife
Partner, Forensic & Integrity Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France
Eugenio Fusco
Deputy Attorney at the Court, Public Prosecutor at the Court of Milan, Milan, Italy
Sylvie Gallage-Alwis, DEA, LLM
Partner, Signature Litigation Avocat à la Cour Solicitor in England & Wales Committees Vice Chair, International Association of Defense Counsel, Paris, France
Abhiroop Gandhi
Trust and Compliance Officer, Verily Life Sciences (an Alphabet company), Former Vice President, Corporate Compliance, Mallinckrodt, San Francisco, CA, USA
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA
Nicola Giovinazzi, EMBA
Corporate Compliance Director, Menarini Group; Former Compliance and Ethics Lead Italy, Switzerland, and Austria, Bristol-Myers Squibb, Florence, Italy
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division; Former Trial Attorney, Civil Division, Fraud Section, US Department of Justice, Washington, DC
Sandra González, JD
Senior Associate, Life Sciences and Healthcare Practice Group, Paul Hastings, New York, NY, USA
Tom Gregory
Partner, Fraud Investigation & Dispute Services, Ernst & Young, LLP, Atlanta, GA
Ulf H. Grundmann
Partner, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany
Ethan Gumpert
Global Ethics, Compliance & Governance, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA
Caitlin Handron, PhD
Senior Lab Consultant and Behavioral Scientist, R&G Insights Lab, Ropes & Gray LLP, Silicon Valley, CA
Joseph W. Henein, PharmD
President and Chief Executive Officer, NewBridge Pharmaceuticals, Dubai, UAE
Bella Rafael Hovhannisyan
Chief Ethics & Compliance Officer, CSL Group; Former Compliance & Ethics Lead, Spain & Portugal, Russia & Turkey, Bristol-Myers Squibb; Berne, Switzerland
Brett Hudson, MBIM
Global Head Ethics, Risk & Compliance Strategy, Innovation, & Corporate Functions, Novartis; Former Global Program Director Integrity & Compliance, Sandoz, Zurich, Switzerland
Mirgen Jaku, MA
Lead of Market Readiness, Digital Surgery, EMEA, Johnson & Johnson, Hamburg, Germany
Franziska Janorschke
Global Head, Business Practices Office, Novartis International AG, Basel, Switzerland
Els Janssens, LLM
Counsel, Baker & McKenzie; Former Legal Adviser, European Medicines Agency; Former Senior Legal Counsel, Johnson & Johnson; Brussels, Belgium
Larisa K. Jasnic, LLB, LLM
Head of Ethics & Compliance, International, Alnylam Pharmaceuticals; Former Regional Compliance Officer, Region Europe, Novartis; Zug, Switzerland
Darren R. Jones
Partner and Leader, Life Sciences Consulting Practice, Baker Tilly, New York, NY
Chelsea M. Keeton, JD
Director and Senior Counsel, Global Compliance Investigations, Zimmer Biomet; Former Group Ethics & Compliance Counsel, VEON, Amsterdam, Netherlands
Iordanis Kerenidis, PhD
Director, Paris Centre for Quantum Computing (PCQC) CNRS Senior Researcher (DR2), Algorithms and Complexity Group IRIF, University Paris Diderot, Paris, France
Elisabeth Kohoutek
Senior Associate, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany
Keith Korenchuk, MPH, JD
Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD, USA
Adem Koyuncu, MD, PhD (Law)
Partner and Chair, Food, Drug & Device Practice Group, Covington; Brussels, Belgium & Frankfurt, Germany
Tomasz Kruk
Head of Compliance, Vifor Pharma; Former Director International Compliance, Mallinckrodt Pharmaceuticals; Former Director Global Ethics & Compliance, Actavis plc (now Allergan); Zurich, Switzerland
Aline Lautenberg, LLM
General Counsel, Director Legal & Compliance, MedTech Europe, Brussels, Belgium
Evelyne Lemaire, MA
Vice President, Head of Ethics & Compliance Global Manufacturing & Supply and Global Quality, Takeda, Zurich, Switzerland
Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin; Former Third Secretary, Ministry of Commmerce, People's Republic of China, Beijing, China; Beijing, China
Abdul Luheshi, MBA
Independent Consultant, Ethics and Compliance; Former Compliance Officer, International Markets, Myriad Genetics; Former Executive Director, Global Operations, Ethics & Compliance, EMEA, Astellas; London, UK
Rosa Magistri, CIPP/E
Head of Legal and Compliance Europe, SeaGen International GmbH; Former Regional Director Office of Ethics and Compliance, Western Europe & Canada, Region South & Israel, AbbVie; Former Associate Compliance Director, Shire; Zug, Switzerland
Sylvain Mansotte
Co-Founder and Chief Executive Officer, Whispli, Sydney, New South Wales, Australia
Anthony McQuillan, LLB
Vice President Legal & Compliance EMEA, Medtronic International; Former Senior Attorney EMEA, Hewlett-Packard; London, UK
Sofie Melis
Director HR and Ethics & Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland
Paul J. Melling, JD
Founding Partner, Baker & McKenzie, CIS, Limited, Moscow, Russia
Genevieve Michaux, JD
Partner, King & Spalding, Brussels, Belgium
Vahan Minassian, JD
Digital Compliance Counsel, Compliance Division, Global Programs, Pfizer, Philadelphia, PA, USA
Philippa Montgomerie, CPE, LLB
Vice President EMEA Compliance and Global Programs, Medtronic Limited, Watford, UK
Arthur Muratyan, Esq.
Secretary General, International Society of HealthCare, Ethics and Compliance Professionals (ETHICS), Chair, MedTech Compliance Panel; Former VP-Head of Legal Corporate and Global Compliance Officer, Sanofi
Sharon Muscato
Director, Compliance Operations, Moderna; Former Director, Transparency & Compliance Operations, Alexion Pharmaceuticals, Inc.; Cambridge, MA
Laura Nassar, PharmD
Vice President, Head of Ethics & Business Integrity, AEME Region, Sanofi; Former Head of Compliance Middle East, Roche Pharmaceuticals; Former Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson, Beirut, Lebanon
Gina Nese, JD
Vice President Global Compliance and Ethics Officer, Align Technology; Former Chief Compliance Officer, Advanced Sterilization Products; Bellevue, WA, USA
Chrisoula Nikidis, LL.L.
Head of Ethics and Compliance, Takeda Canada; Former Vice President, Ethics, Integrity, & Governance, Innovative Medicines Canada, Toronto, Canada
Lauri G. Opar
Head, Enterprise Risk Management & Risk Analytics, Global Ethics & Compliance, Glaxosmithkline, Brentford, Middlesex, UK
John Patrick Oroho, JD
Executive VP & Chief Strategy Officer, Porzio Life Sciences, LLC; Principal, Porzio Bromberg & Newman, PC, Morristown, NJ, USA
Tara Palesh, MS
Senior Director, Compliance Analytics Lead, Pfizer, New York, NY, USA
Pascale Paimbault
President, CEO and Founder, Consulting Alley; Strategic Committee, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Former Executive Director, EMEA Ethics and Compliance, ABAC, Astellas Pharma Europe, Paris, France
Giota Papamarkou
Vice-President, Business Ethics Global, France North America & Global Monitoring, Ipsen; Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb, Paris, France
Carrie (Ashcom) Pennington, MBA, PhD
Vice President, Global Compliance Monitoring & Internal Controls, Zimmer Biomet; Former Global Compliance Manager, Books & Records, GE Healthcare, Warsaw, IN, USA
Oscar Perdomo
Director, Pharmaceutical & Life Sciences, Advisory Services, PwC Switzerland, Zurich, Switzerland
Mario Prohasky
Principal, EMEA Compliance Consulting Lead, IQVIA, London, UK
Ariadna Quesada, MSJ
Compliance Director Europe and MEATI, Hillrom; Former Law, Ethics and Compliance Officer, The Netherlands, AbbVie; Former Compliance Manager International, MicroPort Orthopedics; Amsterdam, Netherlands
Amanda N. Raad, JD
Partner and Co-Chair of Global Anti-Corruption and International Risk Practice and R&G Insights Lab, Ropes & Gray, LLP, London, UK
Nadege Rochel, CCEP-I
Global Compliance Manager, Holister Incorporated, Milan, Italy
David Rodin, PhD
Founder and Chief Executive Officer, Principia Advisory, Former Co-Director, Institute for Ethics, Law, and Armed Conflict, Oxford University, Trélex, Vaud, Switzerland
Christian-Claus Roth
Global Head Scientific Engagement Governance, Novartis; Co-president, International Pharmaceutical Congress Advisory Association (IPCAA); Member, Ethics and Business Integrity Committee, IFPMA, Basel, Switzerland
Fabien Roy
Partner, Hogan Lovells, Brussels, Belgium
Giuseppe Saporito, LLM
Global Legal & Regulatory Expert, IQVIA, Milan, Italy
Pascale Schmidt
Chief Compliance Officer and Chair, Corporate Sustainability Committee, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Brian P. Sharkey
Director, US Commercial Compliance & Ethics, Teva Pharmaceuticals, Parsippany, New Jersey, USA
Michael L. Shaw, JD
Principal, Global Head of Risk & Compliance, ZS; Former Vice President & Compliance Officer - Global Therapy Areas & U.S. Pharma, GSK, Philadelphia, PA
Leonardo Silva, LLM
Vice President, Global Chief Compliance & Privacy Officer, Ferring Pharmaceuticals; Former Head of Compliance, Acino Group, Acino International AG; Former Compliance Director, Emerging Markets, Takeda, Lausanne, Switzerland
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Atlanta, GA, USA
Sara R. Simon, JD
Associate, Porzio, Bromberg & Newman, PC, Morristown, NJ
Sapan Singh, MBA
Senior Director Compliance, Stryker Corporation, Mahwah, NJ, USA
Cerstin Steindorf
Global Account Director Healthcare, MCI, Geneva, Switzerland
Robert Stephenson
Director, PwC UK, London, UK
Heidi Teresi
Director, US Ethics & Compliance, Bausch Health; Former Lead, Education and Communication, US Compliance and Ethics, Bristol-Myers Squibb, Princeton, NJ
Laetitia Thevenon
Compliance and External Collaboration Manager EMEA, ResMed; Former Chair, Compliance Committee, SNITEM, Lyon, France
Madina Torchinova, JD
Vice President, Head Global Compliance, MorphoSys; Former Regional Head of Compliance, Central & Eastern Europe, Middle East & Africa, and Global OTC, Sandoz; Munich, Germany
Nancy S. Travis, MS
Vice President, Global Compliance and Governance, Advanced Medical Technology Association (ADvaMed), Washington, DC, USA
Cláudia Vaz
Head of Market Access and Health Policy, Roche Diagnostics International Ltd., Roche Diagnostics Solutions (RDS), Global Market Access & Public Policy Team (MAPP), Rotkreuz, Switzerland
Steve Vincze, JD, LLM, MBA
President and Chief Executive Officer, Trestle Compliance; SVP & US CCO, Cycle Pharmaceuticals; Former VP, Ethics & Compliance Officer, TAP Pharmaceuticals, Boston, MA
Samar Wakim, PharmD
Ethics & Compliance Head MEA, Innovative Medicines, Novartis Pharma Services AG, Dubai, UAE
Caroline H. West, JD
Former Global Chief Compliance Officer, Olympus Corporation; Former Senior Vice President, Chief Compliance and Risk Officer, Shire, Philadelphia, PA, USA
Vanessa Westphal, JD, MS
Head of Compliance Center of Excellence, Merck KGaA, Darmstadt, Germany
Sarah Wheeler, MA
Director of Global Industry Engagement, International Association for the Study of Pain, Washington, DC
Mariusz Witalis
Partner, Forensic & Integrity Services, EY, Warsaw, PolandFEATURING THE INTERNATIONAL CONGRESS ADVANCED VIRTUAL STREAMING PLATFORM
2021 GLOBAL PHARMA/MED DEVICE ETHICS & COMPLIANCE CONGRESSES
VIRTUAL FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGRESS
Virtual Online Video Event Live and Archived
Sponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
June 14 – 17, 2021
www.InternationalPharmaCongress.com
VIRTUAL TWENTY-SECOND ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGRESS
Virtual Online Video Event Live and Archived Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November, 2021
www.PharmaCongress.com
